ACOTEC SCIEN.H. DL-00001 - Asset Resilience Ratio
ACOTEC SCIEN.H. DL-00001 (7W3) has an Asset Resilience Ratio of 29.34% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 7W3 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2023–2025)
This chart shows how ACOTEC SCIEN.H. DL-00001's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see ACOTEC SCIEN.H. DL-00001 total assets.
Liquid Assets Composition Over Time
This chart breaks down ACOTEC SCIEN.H. DL-00001's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read ACOTEC SCIEN.H. DL-00001 (7W3) total liabilities for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €548.14 Million | 29.34% |
| Total Liquid Assets | €548.14 Million | 29.34% |
Asset Resilience Insights
- Very High Liquidity: ACOTEC SCIEN.H. DL-00001 maintains exceptional liquid asset reserves at 29.34% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
ACOTEC SCIEN.H. DL-00001 Industry Peers by Asset Resilience Ratio
Compare ACOTEC SCIEN.H. DL-00001's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 34.37% |
|
Stratec SE
XETRA:SBS |
Medical Devices | 0.29% |
|
Shinhung
KO:004080 |
Medical Devices | 4.17% |
|
DRTECH Corporation
KQ:214680 |
Medical Devices | 5.18% |
|
Novacyt
PA:ALNOV |
Medical Devices | 0.02% |
|
Diagnostic Medical Systems SA
PA:ALDMS |
Medical Devices | 1.48% |
Annual Asset Resilience Ratio for ACOTEC SCIEN.H. DL-00001 (2023–2025)
The table below shows the annual Asset Resilience Ratio data for ACOTEC SCIEN.H. DL-00001.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 29.34% | €548.14 Million ≈ $640.84 Million |
€1.87 Billion ≈ $2.18 Billion |
+22.56pp |
| 2024-12-31 | 6.78% | €112.80 Million ≈ $131.88 Million |
€1.66 Billion ≈ $1.94 Billion |
-8.21pp |
| 2023-12-31 | 15.00% | €241.58 Million ≈ $282.43 Million |
€1.61 Billion ≈ $1.88 Billion |
-- |
About ACOTEC SCIEN.H. DL-00001
Acotec Scientific Holdings Limited operates as an interventional medical device company that offers vascular interventional treatment products in Mainland China and internationally. The company's products include AcoArt Orchid & Dhalia, a paclitaxel DCB used to prevent stenosis or occlusion in superficial femoral artery and popliteal artery for the treatment of lower extremity artery disease with… Read more